Pena, Michelle J <br/><br/>
A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.  [electronic resource] 

 -  PloS one  2015 
 - e0120995 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0120995  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Adipokines--blood<br/>Adult<br/>Aged<br/>Biomarkers--blood<br/>Bone Morphogenetic Proteins--blood<br/>Chemokine CCL2--blood<br/>Chitinase-3-Like Protein 1<br/>Connective Tissue Growth Factor--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Nephropathies--blood<br/>Disease Progression<br/>Female<br/>Fibrosis<br/>Genetic Markers<br/>Glomerular Filtration Rate<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--blood<br/>Kidney--metabolism<br/>Lectins--blood<br/>Male<br/>Matrix Metalloproteinases, Secreted--blood<br/>Membrane Proteins--blood<br/>Middle Aged<br/>Natriuretic Peptide, C-Type--blood<br/>Outpatients<br/>Prognosis<br/>Prospective Studies<br/>Protein-Tyrosine Kinases--blood<br/>Receptors, Tumor Necrosis Factor, Type I--blood<br/>Renal Insufficiency, Chronic--blood<br/>Risk Factors